MediaPharma srl is a Biotech Company focusing on discovery & development of monoclonal antibodies and antibody-drugs-conjugated to diagnose and to treat cancer and other severe diseases.
The Company, established in 2009 as a spin-off of the “G. d’Annunzio” University Foundation, is based in Chieti, Italy.
Academical Members of MediaPharma:from the Dept. of Experimental and Clinical Sciences:
Stefano Iacobelli – Founder and President,
Nicola Tinari – Cofounder and Senior Consultant R&D,
Other Cofounder: Raffaella Muraro, Clara Natoli, and Mauro Piantelli.
The Managing Team includes Riccardo Palumbo (Member of Board of Directors and Professor of Accounting at our University), Pier Giorgio Natali, Jean-Fred Sauniere, Antonio Zangrilli.
Product pipeline, research product catalogue, contacts, etc. at: http://www.mediapharma.it/
In addition to the development of therapeutic antibodies, current research interest includes the identification and the exploitation of diagnostic, prognostic and predictive markers (and marker clusters) in cancer.
The Company, established in 2009 as a spin-off of the “G. d’Annunzio” University Foundation, is based in Chieti, Italy.
Academical Members of MediaPharma:from the Dept. of Experimental and Clinical Sciences:
Stefano Iacobelli – Founder and President,
Nicola Tinari – Cofounder and Senior Consultant R&D,
Other Cofounder: Raffaella Muraro, Clara Natoli, and Mauro Piantelli.
The Managing Team includes Riccardo Palumbo (Member of Board of Directors and Professor of Accounting at our University), Pier Giorgio Natali, Jean-Fred Sauniere, Antonio Zangrilli.
Product pipeline, research product catalogue, contacts, etc. at: http://www.mediapharma.it/
In addition to the development of therapeutic antibodies, current research interest includes the identification and the exploitation of diagnostic, prognostic and predictive markers (and marker clusters) in cancer.